3 biotech winners for 2006 Peptech:target 2.25, 3 mosBta :...

  1. 113 Posts.
    3 biotech winners for 2006 Peptech:target 2.25, 3 mos
    Bta : target 3 after Glaxo trial
    SRX : Sirtex target $3 short term, $6-7 medium term after large reveunue and profit expansion wnd widespread apllicability of Sir spheres to treat many different metastases to liver with many different chemotherapeutics already underway
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.